ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,919.81
      0.01%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. BriaCell Therapeutics Corporation (BCTX)

      7. BriaCell Therapeutics Corporation (BCTX) Financials

      BriaCell Therapeutics Corporation

      BriaCell Therapeutics Corporation (BCTX)

      NASDAQ
      0.7615
      -0.0084
      (-1.09%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      0.7615
      0.00
      ( 0.00% )
      After Hours: 6:16PM
      Delayed by 15 minutes

      BriaCell Therapeutics Corporation Financial Summary

      The current BCTX market cap is 14M. The company's latest EPS is USD -1.1043 and P/E is -9.60.

      Income Statement

      Annual Quarterly
      Quarter End Apr 2023Jul 2023Oct 2023Jan 2024Apr 2024
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -5.68M-7.71M-8.5M-9.85M-9.27M
      Net Income -4.9M-2.42M6M-11.3M1.72M
      Year End July 30 2023 20192020202120222023
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -5.54M-2.95M-5.55M-15.29M-23.27M
      Net Income -5.79M-4.03M-428k-26.84M-20.3M

      Balance Sheet

      Annual Quarterly
      Quarter End Apr 2023Jul 2023Oct 2023Jan 2024Apr 2024
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 29.72M27.16M18.62M12.23M6.2M
      Total Liabilities 35.61M30.94M16.1M20.55M12.44M
      Total Equity -5.89M-3.78M2.52M-8.32M-6.23M
      Year End July 30 2023 20192020202120222023
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 546k522k58.04M42.58M27.16M
      Total Liabilities 1.39M4.12M782k32.25M30.94M
      Total Equity -846k-3.6M57.26M10.33M-3.78M

      Cash Flow

      Annual Quarterly
      Quarter End Apr 2023Jul 2023Oct 2023Jan 2024Apr 2024
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -12.83M-23.75M-7.61M-15.01M-20.09M
      Investing N/A N/A N/A N/A -225k
      Financing -46k3.95M N/A N/A N/A
      Year End July 30 2023 20192020202120222023
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -5.09M-1.27M-7.75M-12.48M-23.75M
      Investing 1.34M N/A N/A N/A N/A
      Financing 3M1.17M64.99M-3.74M3.95M

      Stats and Ratios

      Market Cap 14M
      Price to Earnings Ratio -9.60
      Price to Sales Ratio 0
      Price to Cash Ratio 9.17
      Price to Book Ratio -51.6
      Dividend Yield -

      Share Statistics

      Shares Outstanding 18.38M
      Average Volume (1 week) 481.52k
      Average Volume (1 Month) 934.18k
      52 Week Change -87.56%
      52 Week High 7.59
      52 Week Low 0.6012
      Spread (Intraday) 0.04 (5.45%)

      Company Info

      Company Name BriaCell Therapeutics Corporation
      Address suite 300 - 235 west 15th street
      vancouver, british columbia V7T 2X1
      Website https://www.briacell.com
      Industry business services, nec (7389)